Kitasato University East Hospital
In research, Kitasato University East Hospital stands highest in Medicine (#16,589 of 17,978 worldwide) and Health Sciences (#19,299 of 20,462 worldwide), over all time. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine and Surgery — Pulmonary and Respiratory Medicine is 8.8× its share of world research.
- World rank, all time
- #40,455 of 42,892
- Rank in Japan
- #1,920 of 2,112
- Research works
- 235 ▼ 68% vs 2013–17
- Citations
- 3k 12.7 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 41% world 28%
What is Kitasato University East Hospital known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #16,589 of 17,978 | 7.7% | 188 | |
| Health SciencesDomain | #19,299 of 20,462 | 7.6% | 196 |
Each strip is that field’s whole ranked pool, with the notch where Kitasato University East Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Kitasato University East Hospital specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 8.8× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 32.9 works8.8×
- SurgerySubfield · 44.3 works7.4×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Kitasato University East Hospital?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Epidemiology, Clinical Practice Guidelines, Endoscopic Resection, Survival Analysis, Gastric Cancer, Molecular Characterization and Neoadjuvant Chemotherapy.
- Esophageal Perforation
- Review
- Palliative Treatment
- Pancreatic Cancer
- Hepatocellular Carcinoma
- Breast Cancer
- Tumor Microenvironment
- Sunitinib
- Imatinib Mesylate
- PET Imaging
- Genetic Mutations
- Neoadjuvant Therapy
- Prognostic Factors
- Inflammation
- Metastatic Gastric Cancer
- Adjuvant Therapy
- Treatment
- Gastric Cancer
- Endoscopic Resection
- Chemotherapy
- Epidemiology
- Clinical Practice Guidelines
- Survival Analysis
- Molecular Characterization
- Neoadjuvant Chemotherapy
- Lymph Node Dissection
- Surgical Management
- Diagnosis
- Immunotherapy
- Pathogenesis
- Prevention
- Complications
- PDGFRA Mutations
- Cholangiocarcinoma
- Children
- Imaging
- Inflammatory Bowel Disease
- Chemoradiation
- Adults
- Endoscopic Stenting
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology32▲ 3.4×44 topics
- Chemotherapy29▲ 18×17 topics
- Clinical Practice Guidelines21▲ 16×10 topics
- Endoscopic Resection19▲ 85×2 topics
- Survival Analysis18▲ 29×4 topics
- Gastric Cancer18▲ 61×3 topics
- Molecular Characterization18▲ 41×3 topics
- Treatment16▲ 5.2×17 topics
- Neoadjuvant Chemotherapy16▲ 76×2 topics
- Adjuvant Therapy15▲ 57×2 topics
- Lymph Node Dissection15▲ 109×1 topic
- Metastatic Gastric Cancer15▲ 109×1 topic
- Surgical Management14▲ 13×10 topics
- Inflammation14▲ 2.5×35 topics
- Diagnosis14▲ 5.7×15 topics
- Prognostic Factors13▲ 12×9 topics
- Immunotherapy11▲ 7.2×10 topics
- Neoadjuvant Therapy11▲ 21×4 topics
- Pathogenesis10▲ 7.7×10 topics
- Genetic Mutations9▲ 7.7×11 topics
- Prevention9▲ 9.8×6 topics
- PET Imaging9▲ 17×3 topics
- Complications8▲ 7.0×8 topics
- Imatinib Mesylate8▲ 57×2 topics
- PDGFRA Mutations8▲ 110×1 topic
- Sunitinib8▲ 110×1 topic
- Cholangiocarcinoma7▲ 39×2 topics
- Tumor Microenvironment7▲ 8.3×4 topics
- Children7▲ 11×5 topics
- Breast Cancer6▲ 9.8×4 topics
- Imaging6▲ 7.8×3 topics
- Hepatocellular Carcinoma6▲ 13×4 topics
- Inflammatory Bowel Disease6▲ 25×4 topics
- Pancreatic Cancer6▲ 22×2 topics
- Chemoradiation6▲ 44×2 topics
- Palliative Treatment6▲ 36×2 topics
- Adults6▲ 35×2 topics
- Review6▲ 19×2 topics
- Endoscopic Stenting6▲ 48×1 topic
- Esophageal Perforation6▲ 48×1 topic
Which research topics does Kitasato University East Hospital publish most on?
By volume in 2022–2025: Probiotics and Fermented Foods, Food Quality and Safety Studies, Tea Polyphenols and Effects and Gastric Cancer Management and Outcomes.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Probiotics and Fermented Foods Food Science 0 works
- 2 Food Quality and Safety Studies Food Science 0 works
- 3 Tea Polyphenols and Effects Pathology and Forensic Medicine 0 works
- 4 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 6 Inflammatory mediators and NSAID effects Pharmacology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Kitasato University East Hospital's research output changed?
Output in 2018–2022 was 68% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.